Current Issue

December 2022

Sickle Cell Syndromes
Sophie Lanzkron and Jane Little, Editors

In the modern era, we have begun to understand how to lessen the risk from homozygous sickle cell disease (SCD) and have seen a welcome expansion in young adults who are surviving childhood, enjoying a longer life, but yet still face significant morbidity and early mortality. This series is an update from the expert sickle cell community about our understanding of the pathophysiology, complications, and treatments of the disease. The series addresses the myriad of complexities in organ function and how to better understand quality of life, in order to provide the reader a broad view through which to approach those affected by SCD.

Articles in Press

There are no Articles in Press at this time

Most Read


The Clinics Journals

Loading ...

Discover everything the Clinics journals have to offer.

About the Journal

Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.